Showing results for tumour microenvironment
[…] we discuss some of the current barriers within tumour immunology, such as immunotherapy efficacy, the tumour microenvironment (TME), as well as potential avenues being explored to overcome this resistance. [/vc_column_text][/vc_column][vc_column column_padding=”padding-2-percent” […]
[…] text_content=”Introduction”][/split_line_heading][vc_column_text] CancerTools.org is committed to empower cancer researchers and the advancement of novel discoveries in tumour immunology by providing relevant research tools, including antibodies targeting tumour antigens. [/vc_column_text][image_with_animation image_url=”28299″ image_size=”full” […]
[…] responses remain the exception rather than the rule. Understanding why requires models that capture the tumour microenvironment, not just tumour growth. This blog explores how the MB49 syngeneic bladder cancer model […]
[…] tablet_width_inherit=”default” animation_type=”default” bg_image_animation=”none” border_type=”simple” column_border_width=”none” column_border_style=”solid”][split_line_heading animation_type=”line-reveal-by-space” font_style=”h3″ text_color=”#ae78b7″ line_reveal_by_space_text_effect=”default” stagger_animation=”true” content_alignment=”left” mobile_content_alignment=”center” link_target=”_self” text_content=” Tumour microenvironment”][/split_line_heading][vc_column_text text_direction=”default”] The tumour microenvironment (TME) is comprised of blood vessels, immune cells, stromal cells, […]
[…] link_target=”_self” text_content=”Disease modelling” text_direction=”default”][/split_line_heading][vc_column_text text_direction=”default”] CancerTools.org provides diverse breast cancer cell lines to accurately model the tumour–microenvironment, metastases, and treatment resistance, to aid scientists uncover new pathways and develop improved in […]
[…] provides diverse lung cancer cell lines including human tumour cell lines to accurately model the tumour–microenvironment, metastases, and treatment resistance, to aid scientists uncovering new pathways and develop improved in […]
[…] microenvironment or genetic changes, is known to have an important role in the growth of experimental tumours. HIF1A has been observed in varying subsets of tumour cells from various solid tumours.
[…] challenges for tumour research is identifying how tumour cells exploit their surrounding cells, the so-called tumour microenvironment (TME), to help form and expand the tumour itself. Existing methods can be used […]
[…] more than 90% of all pancreatic tumours and is characterised by a complex and dynamic tumour microenvironment (TME) that drives disease progression and treatment resistance. Despite significant research efforts, many preclinical […]
[…] from mutations or stable epigenetic changes in genes including adenomatous polyposis coli (APC), kirsten rat sarcoma viral proto-oncogene (KRAS), B-Raf proto-oncogene, serine/threonine kinase (BRAF) and tumour protein 53 (TP53). Only 5% of cases are linked to germline mutations, the vast majority result […]
Please note we may take up to three days to respond to your enquiry.
CancerTools.org uses the contact information provided to respond to you about our research tools and service. For more information please review our privacy policy.
